Cargando…

The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo

PURPOSE: To investigate the effect of the Cdk5 inhibitor olomoucine on corneal debridement wound healing in vivo. METHODS: Corneal debridement wounds of 1.5 mm were made on the ocular surface of CD-1 mice. A 20 μl drop of 15 µM olomoucine in 1% DMSO was applied to the wound area immediately after wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Brajendra K., Stepp, Mary A., Gao, Chun Y., Zelenka, Peggy S.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2274924/
https://www.ncbi.nlm.nih.gov/pubmed/18385789